INS and type 2 diabetes mellitus: The commonly used T2D drugs act by suppressing glucose production in the liver (e.g., Metformin), by enhancing peripheral insulin sensitivity (e.g., Rosiglitazone and other thiazolidinediones), or by forcing the secretion of more insulin from the already-stressed β cells (e.g., sulfonylureas such as Glyburide).